organization · Reporting owner
WAUD CAPITAL PARTNERS MANAGEMENT II, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Acadia Healthcare Company, Inc.
Report date September 14, 2016 · Filed September 16, 2016
Jointly reported with WAUD CAPITAL PARTNERS II, L.L.C., WAUD CAPITAL PARTNERS II, L.P., WAUD CAPITAL PARTNERS QP II, L.P., WCP FIF II (ACADIA), L.P., WAUD CAPITAL AFFILIATES II, L.L.C.
Section 16 reporting ended · disclosed 2016-09-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee footnotes | 4,617,420 |
Reported balance
After 2016-09-14 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2016-09-14 · Sale · Disposed 83,861 · Balance 4,617,420 F1: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee footnotes | 4,393,780 |
Reported balance
After 2016-09-15 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2016-09-15 · Sale · Disposed 223,640 · Balance 4,393,780 F4: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectSee footnotes | 3,872,747 |
Reported balance
After 2016-09-16 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2016-09-16 · Sale · Disposed 521,033 · Balance 3,872,747 F6: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II. F7: The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II. F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II").
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4.
F3: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares.
F4: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4.
F6: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II.
F7: The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II.
F8: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2016 Filed Sep 16, 2016 19:27 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock, par value $0.01 per share | 521,033 | $47.74 | $24,874,115.42 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 3 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,872,747 F6 · shares: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II. F7 · balance_after: The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:27 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock, par value $0.01 per share | 223,640 | $49.24 | $11,012,033.60 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,393,780 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:27 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock, par value $0.01 per share | 83,861 | $50.19 | $4,208,983.59 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,617,420 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 21:04 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock, par value $0.01 per share | 5,933 | $51.23 | $303,947.59 |
DisclosureSEC source: 0000899243-16-029007 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,701,281 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F6 · ownership.nature: The reported shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by Waud QP II, (iii) 418,098 shares by WCP FIF II and (iv) 428,204 shares by Waud Affiliates II. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:04 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock, par value $0.01 per share | 48,321 | $51.77 | $2,501,578.17 |
DisclosureSEC source: 0000899243-16-029007 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,707,214 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 9,095 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 27,464 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 5,811 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 5,951 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 18:56 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | OtherCommon Stock, par value $0.01 per share | 408,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-028907 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,755,535 F1 · kind: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. ("WCP II") and (ii) 193,821 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"). F1 · shares: Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. ("WCP II") and (ii) 193,821 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"). F2 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II (Acadia), L.P. ("WCP FIF II") and the manager of Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F3 · ownership.nature: The reported shares are owned of record as follows: (i) 1,307,585 shares by WCP II, (ii) 2,588,442 shares by Waud QP II, (iii) 424,622 shares by WCP FIF II and (iv) 434,886 shares by Waud Affiliates II. F4 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.